is a multidrug-resistant yeast that has seen a worrying increase during the COVID-19 pandemic. Give7/n this, new therapeutic options, such as controlled-release nanomaterials, may be promising in combating the infection. Therefore, this study aimed to develop amphotericin B (AmB) and micafungin (MICA)-loaded nanoemulsions (NEMA) and evaluated against biofilms of . Nanoemulsions (NEs) were characterized and determined minimum inhibitory concentration MIC, checkerboard and anti-biofilm. NEMA presented a size of 53.7 and 81.4 nm for DLS and NTA, respectively, with good stability and spherical morphology. MICAmB incorporated efficiency was 88.4 and 99.3%, respectively. The release results show that AmB and MICA obtained a release of 100 and 63.4%, respectively. MICAmB and NEMA showed MIC90 values of 0.015 and 0.031 ug/mL, respectively and synergism. NEMA showed greater metabolic inhibition and morphological changes in mature biofilms. This drugs combination and co-encapsulation proved to be a promising therapy against biofilms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08927014.2024.2396020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Severe cutaneous adverse reactions associated with antifungal agents: a pharmacovigilance analysis based on the FDA adverse event reporting System（faers）database.
Expert Opin Drug Saf
December 2024
Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Background: The aim of this study was to explore the risk of severe cutaneous adverse reactions (SCARs) caused by different antifungal drugs in the real world.
Methods: We extracted the data from the FDA Adverse Event Reporting System (FAERS) from January 2004 to December 2022, and performed disproportionality analyses to characterize the signal differences of antifungal agents-related SCARs.
Results: A total of 952 antifungals-related SCARs were identified.
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis.
Infect Dis Ther
December 2024
Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Introduction: Despite the ongoing efforts to refine treatment durations and methods for patients with chronic pulmonary aspergillosis, the clinical use of antifungal agents remains unclear. This study aimed to describe the treatment practices, trajectories, and prognoses of newly diagnosed patients with chronic pulmonary aspergillosis.
Methods: Data from a longitudinal database from hospitals in Japan was used.
MICROBIAL PATTERNS AND DRUG SENSITIVITY TEST OF BACTERIAL AND FUNGAL INFECTION IN COVID-19 PATIENTS AT THE NATIONAL REFERRAL HOSPITAL IN NORTH SUMATRA, INDONESIA.
Afr J Infect Dis
October 2024
Faculty of Public Health, Universitas Sumatera Utara, Medan, Indonesia.
Background: Bacteria or fungi in COVID-19 involves several mechanisms that can affect immune system and also can increase severity of symptoms. The incidence of bacterial or fungal infections is common in patients with viral respiratory tract infections. The aim of this study was to determine the microbial patterns and sensitivity tests of bacterial and fungal infection in COVID-19 patients at National Referral Hospital in North Sumatra, Indonesia.
View Article and Find Full Text PDFCandida Epiglottitis in a Patient Undergoing Chemotherapy for Small Cell Lung Cancer: A Case Report.
Cureus
October 2024
Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, JPN.
Epiglottitis is a critical infection that can result in upper airway obstruction. While bacterial infections are the most common cause of acute epiglottitis, Candida epiglottitis remains relatively rare. We report a case involving an 82-year-old male undergoing chemotherapy for small cell lung cancer.
View Article and Find Full Text PDFCharacterization of Yeast Isolated from the Gut Microbiota of Tunisian Children with Autism Spectrum Disorder.
J Fungi (Basel)
October 2024
Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, UPV/EHU, 48080 Bilbao, Spain.
Article Synopsis
- Research on the microbiota-gut-brain axis in autism has largely focused on bacteria, with fungi being underexplored, prompting a study on fungal involvement in Tunisian children with autism spectrum disorder.
- The study involved fecal sample analysis from 28 autistic children and 46 controls; they identified fungal isolates and tested their antifungal susceptibility and virulence factors.
- Results showed a significant presence of fungi in both groups, with specific antifungal resistance and virulence traits in the isolates, indicating a potential link between gut fungi and autism that warrants further investigation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!